Показано 0 из 0
Дата |
---|
17.05.2024 |
08.05.2024 |
07.05.2024 |
06.05.2024 |
03.05.2024 |
02.05.2024 |
01.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
0.6026
|
1.20
|
0.88
|
0.88
|
0.88
|
0.88
|
|
|
280.47
|
8.00
|
0.5612
|
1.20
|
0.785
|
0.6175
|
0.80
|
0.66
|
|
|
37 633.75
|
1 033.00
|
0.5612
|
1.20
|
0.75
|
0.61
|
0.75
|
0.61
|
|
|
12 962.08
|
270.00
|
0.70
|
1.20
|
0.74
|
0.7057
|
0.75
|
0.75
|
|
|
11 529.99
|
256.00
|
|
1.20
|
0.58
|
0.47
|
0.70
|
0.675
|
|
|
18 082.07
|
355.00
|
|
1.20
|
0.311
|
0.311
|
0.44
|
0.44
|
|
|
11 276.11
|
41.00
|
|
1.20
|
0.4505
|
0.4489
|
0.46
|
0.46
|
|
|
25 792.66
|
132.00
|
|
1.20
|
0.58
|
0.46
|
0.60
|
0.47
|
|
|
48 553.67
|
168.00
|
|
1.20
|
0.45
|
0.45
|
0.60
|
0.59
|
|
|
5 260.96
|
60.00
|
|
0.48
|
0.3525
|
0.3525
|
0.44995
|
0.40
|
|
|
17 009.92
|
60.00
|
Zura is a clinical-stage biotechnology company advancing immunology assets into Phase 2 development programs, including ZB-168 and torudokimab.